Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants.

Literature DB >> 12965896

Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants.

Albrecht Leo¹, Susanne Winteroll.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Anticoagulants
Heparin

Year: 2003 PMID： 12965896 PMCID： PMC193890 DOI： 10.1128/cdli.10.5.731-740.2003

Source DB: PubMed Journal: Clin Diagn Lab Immunol ISSN： 1071-412X

× No keyword cloud information.

73 in total

1. Temporal aspects of heparin-induced thrombocytopenia.

Authors: T E Warkentin; J G Kelton
Journal: N Engl J Med Date: 2001-04-26 Impact factor: 91.245

Review 2. Heparin-induced thrombocytopenia: towards consensus.

Authors: T E Warkentin; B H Chong; A Greinacher
Journal: Thromb Haemost Date: 1998-01 Impact factor: 5.249

3. Laboratory tests for heparin-induced thrombocytopenia: a multicenter study.

Authors: J M Walenga; W P Jeske; J J Wood; S Ahmad; B E Lewis; M Bakhos
Journal: Semin Hematol Date: 1999-01 Impact factor: 3.851

4. A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT).

Authors: W Jy; W W Mao; L L Horstman; P A Valant; Y S Ahn
Journal: Thromb Haemost Date: 1999-10 Impact factor: 5.249

5. Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance.

Authors: P Eichler; H J Friesen; N Lubenow; B Jaeger; A Greinacher
Journal: Blood Date: 2000-10-01 Impact factor: 22.113

Review 6. Assays for heparin-induced thrombocytopenia.

Authors: E Griffiths; W H Dzik
Journal: Transfus Med Date: 1997-03 Impact factor: 2.019

7. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay.

Authors: A Greinacher; J Amiral; V Dummel; A Vissac; V Kiefel; C Mueller-Eckhardt
Journal: Transfusion Date: 1994-05 Impact factor: 3.157

8. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia.

Authors: J G Kelton; D Sheridan; H Brain; P J Powers; A G Turpie; C J Carter
Journal: J Lab Clin Med Date: 1984-04

9. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.

Authors: G P Visentin; S E Ford; J P Scott; R H Aster
Journal: J Clin Invest Date: 1994-01 Impact factor: 14.808

10. Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.

Authors: T E Warkentin; C P Hayward; C A Smith; P M Kelly; J G Kelton
Journal: J Lab Clin Med Date: 1992-09

6 in total

1. Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia.

Authors: Tiffany K Pon; Anjlee Mahajan; Aaron Rosenberg; Alpesh Amin; Digish Shah; Ian Jenkins; Vineet Gupta; Heather Hofmann; Anthony Bejjani; Richard White
Journal: J Thromb Thrombolysis Date: 2018-05 Impact factor: 2.300

2. In vivo and in vitro cross-reactivity to fondaparinux in a stroke patient with IgG-PF4/heparin antibody-negative delayed-onset heparin-induced thrombocytopenia.

Authors: Ivan Krečak; Gordana Tomac; Jakša Škugor; Velka Gverić-Krečak; Dražen Pulanić
Journal: Blood Transfus Date: 2020-06-04 Impact factor: 3.443

Review 3. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.

Authors: Daniela R Junqueira; Liliane M Zorzela; Edson Perini
Journal: Cochrane Database Syst Rev Date: 2017-04-21